{"schemaVersion":"peptidescanner-clinical-trials-history-bundle/v1","canonicalUrl":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json","manifestUrl":"https://peptidescanner.com/clinical-trials-history/v1/manifest.json","peptideSlug":"tesamorelin","addressing":"objects is keyed by the lower-case NCT number. A URL fragment #<nct number> on this file names one trial's history object.","objectCount":10,"objects":{"nct00608023":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00608023","recordId":"NCT00608023","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00608023-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct00608023","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct00608023"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2008-01-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2008-01-23","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"12e98db2ec3c733309e7a0ed1757dc6502526f82f1cc8af1a4f4281fdd01bbc0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-11-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2011-11-22","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"05edc770a8b22d48ba0cc0786d9113f1a43a75ac19333752e69a4f4e45cb4385","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Outcome Measures","Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2013-11-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2013-11-25","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"b13b06f1ea0798629a4b43c7bd16fcdec4c9dc7dc93b3b7bf1af3f854f39643e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2013-11-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2013-11-27","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"bd416e533aab2bdc7ceb5cf757748cf2b7acbdf8498453ef37c05c0fce8e0d4a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2014-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2014-03-27","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"f57cc52ec770a4eedbb4fe454c6b1ee3dc86dd6f2f6ec9823d62905e6ceb8628","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures (Results)","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2022-03-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2022-03-29","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"0b35352604ec39a39acbd83e0cbbbb3ba73d04d766558cfc6aadb8cfe4ea6b3b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","More Information","Study Description","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2022-03-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2022-03-30","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"6b7efe6ea71363fd906bc70a8e03f917d36c7836df25d11c36243b3e08a33ce3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Limitations and Caveats","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2022-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2022-09-16","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"12384bdc9ee3335b002f715019b68457abb1254d2fa8dde0e210961df86b1177","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"5a033963ca0bec7b12ff5bc9b5fa2680b87d4fa51c49a84483d517270d1115c5"}},"nct00850564":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00850564","recordId":"NCT00850564","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00850564-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct00850564","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct00850564"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2009-02-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2009-02-23","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"ff2fd4a0daec5c10c576b45e212ef52b652e545205d02e5aac5a5a4dc2e36e12","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2009-08-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2009-08-06","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"9b4152ec5c02ad2fe899695b034015c54659490a1253bafdeb35f1b89d52116b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2010-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2010-04-01","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"e4c8cdf6d2c03afda6e93748fba9e19be40e31c991fbf0bee22646c7b03f741d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2010-10-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2010-10-04","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"3e693ede9402e834028091f08dad1ac4700dceba7bc46b1a94494e754620da3a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2011-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2011-03-03","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"3f85d1698a905e338f070f9e3a3cb2f7c6e168b141eb8e12532a8d618d02b36a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2011-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2011-04-15","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"b4a2752190d036de168c9e73c9add2850436ae63165707484e994ebe8a742dbb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=6&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"dba8e056f1257935ecaec16d5cc85739cfb245f88c302c7d36a779fad89db836"}},"nct01263717":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01263717","recordId":"NCT01263717","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01263717-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct01263717","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct01263717"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2010-12-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2010-12-20","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"2b41403d6278e5a010b9a5b59b24b3e3b349fc37d31e10ea6380e011f6be074a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2011-04-15","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"a61a8728ceb4711d5a6f22b583b513fd4fa3a9003b0e79e0f7cad661f8e0aa43","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2011-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2011-10-05","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"12a4e4e036ace843520fe47cb7113476a4e9d7adf693ffdaa3b3340e1e3b55d9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2012-04-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2012-04-18","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"51580889575ff5893c6148419ce53dfa9338a929ce5048d5dc6521dd1190329a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2012-11-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2012-11-09","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"ef382093d098153dbee9344f8e49a4ec4b7db1501b66e2e82c8726d949336b75","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2013-03-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2013-03-12","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"c6cb29561e47d1351e8be4a4a5e6ce7c2384fe71dd4dad5fc4ffbe9dae5f197e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2013-08-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2013-08-27","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"68f1fc3349bffb82fd0ad5d8031e4cb855283aa3b2f5bf6ff8e4072b25b14bbd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2014-05-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2014-05-02","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"68474d0ae059831658885b85e1daf3be404ed7991e247cdc2d65c2ba6cd0e639","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Contacts/Locations","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Design","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2014-10-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2014-10-10","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"91dda507d28b15877972684ae00a251797e09cd2bb8d0447661d69f592c3c7de","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Limitations and Caveats","Outcome Measures (Results)","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2017-09-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2017-09-28","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"81f11902464f8176f00608d889b2378edbf3d351cc875f02532fea2df69c9e6e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=10&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"536bfc3f9f2f969383aee2b8ef5a32ca9b971f5fa7fe072509ccb1a9d3561f7c"}},"nct02196831":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02196831","recordId":"NCT02196831","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02196831-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct02196831","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct02196831"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-07-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2014-07-21","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"5299cdd2724b5604359d8a018327174b4b1c034ffa6839bf19f35005c7578a6a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-07-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2014-07-22","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"e85bf6cfe45407434bd41789982f2b9448f7fdda9393bb7bbaa8614539018dc9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2014-10-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2014-10-14","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"3568932e42b915078affe8a488ee674cd8332357980425619431162c72f25eca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-02-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-02-18","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"95c06aa77b4751d92e57ac318d6f6c35caf38a06900c0654d4b25809bab42f61","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Oversight","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2015-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-07-16","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"b56190243fdac7ec6a7c2846094f555d60b30fec4b286432e86a548280aa7c61","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2015-10-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-10-28","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"55cc7a4380ef210c57c7c2941b161c97ac0dcca33cb5083f88bbfdae845cc893","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2016-03-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2016-03-14","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"0952999c1188b9abffd1f2424c5b45b450e1fe2182b7312975e3afc121711b29","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2016-08-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2016-08-19","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"1021acb14b218e9a75d8aa09359f7686b93e6b5b355ee42c3f77f45694365eda","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2017-08-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-08-28","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"ea197453e41eae96ea4655088bd032d4dea31f570f03cc7e9e7a644a6a08dc5f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2018-02-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-02-03","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"a80087d13f24637633eff6a5b5456a572ccc284f5ca27a03219812cba6761f15","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2018-10-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-10-19","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"5ca2ed070a4c79120b6ded802ab120226aa346d62016821938f40b94ab3f510f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2019-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2019-12-19","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"02f4496c4b1afc021f348f0ebe1530845abd67853814d93caefce56f1380045c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2020-01-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2020-01-13","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"f2094e86e64d287b5ee185df577baf02a7383d61e3cf75e055e540727fae60b4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=14&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"7ed42b3d1bd8e46f2ed244fb816631235524d8503f8be577c90024b8c55ce008"}},"nct02553603":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02553603","recordId":"NCT02553603","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02553603-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct02553603","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct02553603"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-09-16","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"da5b8baff648b7e7db741a9cc0113829f096399976b033ab74dd09eb7d18f537","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-05-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2016-05-10","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"4d3798e06c6d8ae75cfd1094d4d68b84c9b33178966b71e0367de99303b0049d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Eligibility","Outcome Measures","Oversight","Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-08-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-08-15","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"f1329b64f05bc074cc4ce63fd5fed2b32d4fc3adea517eacd469c54bba42e67a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Study Description","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-02-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-02-14","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"09debcfe7d47b3ecf9b0f84086a8df59b93d04fef6a9e76701ea3791134bd69e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-07-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-07-09","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"daa2f5785230ed956b31fdc3890de6ce71c1674364ed2c551d463ac299a05fef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-04-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2019-04-16","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"37255e5525e0af29b785dbb8aab56c6769a09a9043897eddce346cd01c5dc431","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2019-11-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2019-11-01","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"c4053ffc6caad15f2a676dff3d199052cff489612a7cecca1dff586b1cacdc43","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"16f0be452236a49626f668b50450a012c4d9a21162ac8890ac72845bb6378642"}},"nct02572323":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02572323","recordId":"NCT02572323","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02572323-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct02572323","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct02572323"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-10-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-10-07","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"6bd60f5b566f040199bfeeaf06e358542d92944ba0c099d8e419e589447a5693","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-10-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-10-21","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"ffa911dea2d4e6572bbba0349d36421ca67cc6863daa6180f54b9c43a14874c2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Description","Study Design","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2016-02-04","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"29b5bc9d542adc0cc2bea293a36a6735ce69afbaa8079e303522ed63714e599b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","IPDSharing","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-10-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2016-10-24","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"ca8913bdb74417659c11dd6d9341e59692f6f2a674ecdd81151575d350f14394","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Eligibility","Outcome Measures","Oversight","Study Description","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-02-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-02-16","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"1cf1f9d3a43541a124d8a4ae2aabb5e1c9ab28fa24cc825e8fb4d9c4f908aef6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Description","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-10-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-10-24","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"340088aedcd318c2c05b0504ff75591bf9d8c4d68e281cd35740297dd3bde47a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2019-03-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2019-03-20","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"006d711c0b835e1d79d85f1846a980ceab4d82414b0fd313b3b01101cfb117da","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2020-03-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2020-03-25","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"577c9c404876ea63a8512ff7d7d6fa249a06ec2470eb340aa98638044080b99d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Description","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2021-04-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2021-04-30","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"54e97bd4b2e0e81b79ed3cfe6329135b6c4fcd0424c626d98f3b8eb451465847","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2022-07-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2022-07-06","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"684674badf9c3aef1c0f508a6b6b7e72b8c711de227703c05dbf7d5a6972cc8e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2023-04-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2023-04-26","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"0af6d294ea6b92e9a46f30d148da1d5e9d33b3d3df0766a2ddff74a6659b9e11","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2024-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2024-05-03","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"791d5de9875f5e1312124e28b875a9df95b92034d444da41fbd5d5baa79ab18f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2026-03-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2026-03-04","publishedAt":"2026-08-23","recordId":"NCT02572323","recordSha256":"4a39e99be6d207917ddcd5d0d18e252f77ccd49071723dffc284594caefb96ff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02572323?a=16&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"f413f47e99d96b0d9897c2f392a2cfaf933f4132290684711a729c18035dfcd7"}},"nct03150511":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03150511","recordId":"NCT03150511","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03150511-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct03150511","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct03150511"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-05-09","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"e2c332aaedfe89baf7539fe276e46ff8649357bad52b43cc85dd8a2f56fae09e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-02-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-02-13","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"e84394272212165fc5ff66585a9f65d6b2c93d9ab1d536f1bf26532fa8609ac9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-05-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-05-22","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"de1d1a437c3686f30ea623cc34eb6fb0cc3ee9038c31e647d17bb49b5f5f5796","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-07-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-07-12","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"d70db16e095712caa48c96b14ee8651c3c652781183c41549f5a46ef23f8b34c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2019-02-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2019-02-07","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"41e913a97f04e56e3dbb0b0abd31d19df38984155db9e147e03b67a51c64d27e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2019-05-09","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"e329745b8ade8021f1be7b02db3a895e430570e4df10c04ec2bf0ba87eebe005","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2020-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2020-05-19","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"db2fceb71ceb815e6aa023c8ab33fd209f8094847098b62064d3045ba7326ba1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2020-12-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2020-12-08","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"c0fff8afc9ef8f9862d661c79af5f00797aaa58a9aa55bbc850bacf3375458ff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2021-12-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2021-12-07","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"649c2ff774d1cbfde1c6f9aeb19c05ee9f9bea7d11061a38488b43343f2ff106","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2022-12-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2022-12-06","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"40b81b0c89c379bf6a161ef8284b2b76bfad649dc43c3132e9ceac96a5b5aebb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Identification","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2023-08-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2023-08-08","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"d805c497d06796c67accf8fba4232da8a82f013f872d3fe02bc6a610b83e7d16","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2024-09-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2024-09-04","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"38d314146b0ea3d320faba27626033778b6d402201c3ff9026ae64047a351ba4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Outcome Measures","Study Description","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2024-11-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2024-11-08","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"607ea2a2a8db86d65dacc6768b4bb6a3752d76d5bf8f7612466c83333772dc00","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2025-11-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2025-11-10","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"1764ff87f83c14fe0e29b404cd422ea5e369a436969b17a6e80fcb25d676eb55","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=14&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"72d25ea43fd00933a0d7827b638cd87396338005fcb55acc354da9c19f2ee678"}},"nct03375788":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03375788","recordId":"NCT03375788","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03375788-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct03375788","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct03375788"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-12-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-12-13","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"f29ddafb86ac33f4f800e50592be16645a05af9fe21e4bb0c31e732c4d87e262","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Conditions","Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-12-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-12-15","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"9117437b792f307424d986653641ec22bd6dbd549eaa4b65e9ff5093d206eca6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-08-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-08-14","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"4f8a9d127855547d30fbda728f17cc25101035dc69f8acc1ee46c632bef7d731","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-10-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-10-19","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"b7315ca1cefd241efc7d0949da64519ece42c7b51156a99e40ebed4b3c6cdf1f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Sponsor/Collaborators","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2019-02-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2019-02-21","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"5228676b5e5d0d95c5e9d1173d0731cf83c1f9907f17df52bafb851c9a9b1cec","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-11-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2019-11-19","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"431b08e31e2f8eb4ee344d1d1cd1f013bbe0bf53016e802b1e9787054b27a4f3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2021-03-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2021-03-29","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"6055a576b9bcce373580c16a15e1be38e2e119e8846d74ff28dbd7d6458d0c80","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2022-08-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2022-08-11","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"500abdd7cad92b58eabac23d8084a163fb1402ede4c10e0feff6a68960fb3e6e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2023-05-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2023-05-29","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"5210e37bebab0d9673932c40b4902933a709f7f9d2aa06368974c7a37ad182c0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Oversight","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2024-09-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2024-09-11","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"7d6b65e6e69d2998a244a444c10068f395d048fdaee51e1555fe3b6b68670ac4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2025-11-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2025-11-06","publishedAt":"2026-08-23","recordId":"NCT03375788","recordSha256":"96f23bb33b391960f901b9ca8a45c8936b23118896ef6cd7f66df5a5e5d74c62","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03375788?a=14&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"9d4b8b5d42abbf22db32d59f0931bf0bfd7d3905f2a6af2dbdfcebf215b1c23b"}},"nct06554717":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT06554717","recordId":"NCT06554717","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06554717-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct06554717","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct06554717"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2024-08-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2024-08-12","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"7f93b741341172798fc50195ef5e30cd1d74a92be4970c114483d91a80ce4f04","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2024-08-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2024-08-15","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"87f32760202459f86c20309ac91c2942b1b7fd44fdb63a4e58856b240854d892","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-04-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2025-04-25","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"1e939aaa81b5e139fe2fb81b98f09dd0b3999597752665983d0312c08e349716","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Oversight","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2025-05-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2025-05-23","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"c7223ac8f46b7e2b1165555a08c69352b41ebca28d6169515e0a636a36b312bc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-07-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2025-07-28","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"bec91eb5e6a368636be6da671e2b6979b66f7426005c6e4e85776d303a47328e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2026-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2026-05-13","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"8b78805533f5ac233011f78fef2238be27fac2149c889d90cbf10c3158701ab7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2026-05-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2026-05-15","publishedAt":"2026-08-23","recordId":"NCT06554717","recordSha256":"32cb089f56934b121547fadc4eac8f12c646df6d3f5a11a39a6c225f515a42ed","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06554717?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ee92be3befdcf2811a33bb204c26d1a6db98a95558e85ab68f6a5c7a275561ef"}},"nct07481734":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07481734","recordId":"NCT07481734","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07481734-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct07481734","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.md#nct07481734"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2026-03-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2026-03-14","publishedAt":"2026-08-23","recordId":"NCT07481734","recordSha256":"7f4f107e7b8f3dd9e0c3ca23e883ec1e67815093b9cab18e732947b85158c3f3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07481734?a=1&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"8edab4e114a94d34dd76930d4ca586449b115d37538b3be69f3c17d49d4d69ad"}}}}
